Voloridge Investment Management, LLC Hutchmed (China) LTD Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$27.01 - $36.8 $617,826 - $841,763
-22,874 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$27.51 - $34.36 $383,792 - $479,356
-13,951 Reduced 37.88%
22,874 $732,000
Q3 2020

Nov 16, 2020
BUY
$25.8 - $34.61 $950,085 - $1.27 Million
36,825 New
36,825 $1.19 Million
Q4 2019

Feb 14, 2020
SELL
$17.17 - $25.95 $417,728 - $631,337
-24,329 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$17.84 - $22.69 $434,029 - $552,025
24,329 New
24,329 $434,000

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email